StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
GOEL.BO$14.10+0.00%
Fair $14.10+0.0%

GOEL.BO

Goel Food Products Ltd

Consumer Defensive / Packaged FoodsBSE

$14.10

+0.00 (+0.00%)

Fairly Valued+0.0%Fair Value $14.10Fund rank 24/100 · Data gapFallback financials|
SA 50/C
F-Score: 5/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 16%

FCF escenarios

weak_data · normalized FCF $63.9M · quality 36.7/100

Data gap 24/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 17/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

50/100

C

Piotroski

5/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified.
Thesis & Journal · GOEL.BOLocal privado en este navegador · Goel Food Products Ltd
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$266M

P/E

5.3x

↓

EV/EBITDA

4.8x

↓

ROE

18.7%

↑

Gross Margin

62.4%

↑

Debt/Equity

0.98

↑
52-Week Range$14
$9$20

TradingView lightweight chart

GOEL.BO price, volumen y niveles de valoración

Último $14.10Periodo -10.5%
Fair value: $14.10

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+12.6%

FCF CAGR

—

FCF margin

27.9%

FCF / Net income

1.30x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $235.7M · net income $50.6M · FCF $65.8M

2022-FY → 2025-FY

Gross margin

62.4%-1.1% pts

Operating margin

34.9%+7.4% pts

Net margin

21.4%+7.4% pts

FCF margin

27.9%+102.5% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$235.7M$235.7M$241.1M$224.9M$165.1M
Net Income$50.6M$50.6M$50.0M$40.3M$23.1M
EBITDA$102.2M$102.2M$105.9M$91.0M$56.6M
EPS2.682.682.652.211.23
Gross Margin62.4%62.4%67.4%64.3%63.5%
Operating Margin34.9%34.9%36.8%30.8%27.5%
Net Margin21.4%21.4%20.7%17.9%14.0%
Balance Sheet
Debt/Equity0.980.981.331.873.05
Current Ratio1.521.52———
Cash Flow
Free Cash Flow$65.8M$65.8M$63.9M$-39.0M$-123.1M
Returns
ROE18.7%18.7%22.5%23.4%23.5%
Valuation
P/E5.345.3410.6313.60—
EV/EBITDA4.824.827.489.37—
P/B0.980.982.393.18—
Growth & Yield
Revenue Growth-2.2%-2.2%7.2%36.2%—
EPS Growth1.1%1.1%20.1%79.9%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

-22.4%

fácil

EPS terminal req.

$1.25

Spread vs growth

23.6%

5Y implied EPS CAGR

-10.8%

fácil

EPS terminal req.

$1.51

Spread vs growth

11.9%

10Y implied EPS CAGR

-0.9%

fácil

EPS terminal req.

$2.44

Spread vs growth

2.1%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -18.6%

Total return

-18.6%

Start / end P/E

6.5x → 5.3x

EPS bridge

2.65 → 2.68

Residual

-0.2%

EPS growth+1.1%
Multiple rerating-19.5%
Dividend+0.0%
Residual / FX / buybacks / cross-term-0.2%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.